Results 181 to 190 of about 4,150,951 (316)

Mechanisms of drug allergies (BSACI session)

, 2002

openalex   +2 more sources

Allergic diseases of the skin and drug allergies – 2004: Clinical and immunologic characteristics of allergen-specific immunotherapy in children with atopic dermatitis [PDF]

, 2013
Tatiana Slavyanskaya, В. В. Деркач   +1 more
openalex   +1 more source

Targeting Neutrophil/Eosinophil Extracellular Traps by Aptamer‐Functionalized Nanosheets to Overcome Recalcitrant Inflammatory Disorders

Advanced Science, EarlyView.
In this study, C‐TAH, as multifunctional nanosheets, is developed with tannic acid and histone aptamer coverage. C‐TAH displays mild cytotoxicity, robust dsDNA and NETs/EETs binding efficiency, and potent antioxidant and antibacterial ability in vitro. C‐TAH treatment ameliorates dysregulated inflammation and restores hearing function in animal models,
Yongqiang Xiao, Xinyue Wang, Ming Liu, Xiao Fu, Nanfeng Zhang, Wenqing Yang, Junyi Ge, Yangyang Li, Duan Ma, Jing Ma, Weiping Wen, Dongdong Ren, Tianyu Zhang, Zhaoxu Tu   +13 more
wiley   +1 more source

Controversies in drug allergy: Testing for delayed reactions.

Journal of Allergy and Clinical Immunology, 2019
E. Phillips, P. Bigliardi, A. Bircher, A. Broyles, Yoon-Seok Chang, W. Chung, R. Lehloenya, M. Mockenhaupt, J. Peter, M. Pirmohamed, J. Roujeau, N. Shear, L. Tanno, J. Trubiano, R. Valluzzi, A. Barbaud   +15 more
semanticscholar   +1 more source

Desensitization in delayed drug hypersensitivity reactions – an EAACI position paper of the Drug Allergy Interest Group [PDF]

, 2013
Kathrin Scherer, Knut Brockow, Werner Aberer, J. H. C. Gooi, Pascal Demoly, Antonino Romano, Benno Schnyder, Paul Whitaker, J. S. R. Cernadas, A. J. Bircher   +9 more
openalex   +1 more source

ER‐phagy Activation by AMFR Attenuates Cardiac Fibrosis Post‐Myocardial Infarction via mTORC1 Pathway

Advanced Science, EarlyView.
By catalyzing FAM134B ubiquitination and activating ER‐phagy, AMFR alleviates progressive fibrosis and cardiac dysfunction by inhibiting the mTORC1 pathway. Consequently, these findings underscore the essential role of AMFR‐driven ER‐phagy in mitigating the progression of fibrotic responses, offering a potential therapeutic target for preventing heart ...
Zhixiang Wang, Kaifan Niu, Wei Liu, Xinyun Wang, Boshen Yang, Taixi Li, Yizhi Chen, Yuanyuan Jin, Yu Chen, Yangyi Lin, Xian Jin   +10 more
wiley   +1 more source

Evaluation of Frequency and Characteristics of Drug Allergy in Pediatric Patients with Cystic Fibrosis. [PDF]

Pediatr Allergy Immunol Pulmonol, 2022
Şengül Emeksiz Z, Metbulut P, Akyan Soydaş ŞS, Tuğcu G, Cinel G, Dibek Mısırlıoğlu E.   +5 more
europepmc   +1 more source

Allergic diseases of the skin and drug allergies – 2013. Longitudinal analysis of fecal microbiota of infants followed-up for eczema till 2 years of age [PDF]

, 2013
Gaik Chin Yap, Christophe Lay, Marion M. Aw, Lynette Shek Pei-Chi, Yudong Zhao, Doreen Leow, Bee Wah Lee   +6 more
openalex   +1 more source

The Immune Microenvironment: New Therapeutic Implications in Organ Fibrosis

Advanced Science, EarlyView.
This review summarizes recent advances in understanding the immune microenvironment's role in fibrosis, focusing on phenotypic/functional alterations of immune cells and their dynamic interactions with other cellular constituents within tissues. The authors further explore therapeutic opportunities and challenges in targeting immune microenvironment ...
Xiangqi Chen, Chuan Wu, Fei Tang, Jingyue Zhou, Li Mo, Yanping Li, Jinhan He   +6 more
wiley   +1 more source

Classic autoimmune type 1 diabetes mellitus after a case of drug reaction with eosinophilia and systemic symptoms (DRESS). [PDF]

, 2018
Chapman, Lance W, Chiang, Audris, de Feraudy, Sebastien, Elsensohn, Ashley N, Shiu, Jessica, Smith, Janellen   +5 more
core   +1 more source